InvestorsHub Logo

H2R

Followers 41
Posts 2215
Boards Moderated 0
Alias Born 07/17/2014

H2R

Re: thermo post# 463

Saturday, 03/19/2022 6:40:12 PM

Saturday, March 19, 2022 6:40:12 PM

Post# of 1053
Hi Thermo,

Your posts have that honesty and rational ring to them. I appreciate your sharing your thoughts with others. And I bet I am far from the only one.

Compared with a number of other biotechs with high potential, the OTLK story is more straightforward.

I hope they continue to keep their planned timeline and that we hear about the BLA submission within the next couple weeks or so, as per their Feb. 14th PR "With the registration clinical trials completed, Outlook Therapeutics plans to submit a new BLA under the Public Health Service Act (PHSA) 351(a) regulatory pathway in the first quarter of calendar 2022. "
https://ir.outlooktherapeutics.com/news-releases/news-release-details/outlook-therapeutics-reports-financial-results-first-quarter-0

Best of luck with your investments!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent OTLK News